These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27639260)

  • 21. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics and pharmacodynamics of antibiotics in septic children treated with extracorporeal membrane oxygenation].
    Zhang HX; Huang JT; Dong J; Gong TZ; Zhang KY; Lu XL; Guo SW
    Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):631-636. PubMed ID: 37385807
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
    Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H
    BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation.
    An SH; Lee EM; Kim JY; Gwak HS
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e25-e29. PubMed ID: 32296501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest.
    Bělohlávek J; Springer D; Mlček M; Huptych M; Bouček T; Hodková G; Fichtl J; Mrázek V; Zima T; Linhart A; Kittnar O
    Pulm Pharmacol Ther; 2013 Dec; 26(6):655-60. PubMed ID: 23524014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation.
    Zhang LC; Li QY; Zhang YQ; Shan TC; Li Y; Li YH; Han H; Qin WD; Guo HP; Zhao W; Tang BH; Chen XM
    J Antimicrob Chemother; 2024 Jul; 79(7):1697-1705. PubMed ID: 38814793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.
    del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A
    Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support.
    Zylbersztajn B; Parker S; Navea D; Izquierdo G; Ortiz P; Torres JP; Fajardo C; Diaz R; Valverde C; Roberts J
    Front Pharmacol; 2021; 12():709332. PubMed ID: 34483917
    [No Abstract]   [Full Text] [Related]  

  • 36. Population pharmacokinetics of vancomycin in Chinese infants
.
    Sheng XY; Chen CY; Ma LY; Liu YO; Zhou Y; Cui YM
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):558-566. PubMed ID: 28406088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
    Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
    J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation.
    Yang S; Noh H; Hahn J; Jin BH; Min KL; Bae SK; Kim J; Park MS; Hong T; Wi J; Chang MJ
    Sci Rep; 2017 Nov; 7(1):16276. PubMed ID: 29176598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation.
    Sinnah F; Shekar K; Abdul-Aziz MH; Buscher H; Diab SD; Fisquet S; Fung YL; McDonald CI; Reynolds C; Rudham S; Wallis SC; Welch S; Xie J; Fraser JF; Roberts JA;
    Crit Care Resusc; 2017 Oct; 19(Suppl 1):8-14. PubMed ID: 29084496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.